Rare chromones from a fungal mutant of the marine-derived Penicillium purpurogenum G59

Marine Drugs

Volumn 13, Issue 8, 2015, Pages 5219-5236

  Xia, Ming Wen ^a,b   Cui, Cheng Bin ^a,b   Li, Chang Wei ^a   Wu, Chang Jing ^a,b   Peng, Ji Xing ^c   Li, De Hai ^c  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Chromone derivatives; DES mutagenesis; ECD; Epiremisporine; Isoconiochaetone; Marine derived fungus; Penicillium purpurogenum G59; Remisporine

Indexed keywords

CHROMONE DERIVATIVE; CONIOCHAETONE A; DIETHYL SULFATE; DOCETAXEL; EPIREMISPORINE B; EPIREMISPORINE B1; ISOCONIOCHAETONE C; METHYL 8 HYDROXY 6 METHYL 9 OXO 9H XANTHENE 1 CARBOXYLATE; REMISPORINE B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; SULFATE;

ARTICLE; BGC 823 CELL LINE; CANCER CELL LINE; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HELA CELL LINE; HL 60 CELL LINE; HUMAN; HUMAN CELL; K562 CELL LINE; KARYOTYPE; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PENICILLIUM PURPUROGENUM; AQUATIC SPECIES; CHEMISTRY; DRUG EFFECTS; FUNGUS; K-562 CELL LINE; METABOLISM; MUTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PENICILLIUM; PROCEDURES; TUMOR CELL LINE;

FUNGI; PENICILLIUM PURPUROGENUM;

ANTINEOPLASTIC AGENTS; AQUATIC ORGANISMS; CELL LINE, TUMOR; CHROMONES; CIRCULAR DICHROISM; FUNGI; HUMANS; K562 CELLS; MAGNETIC RESONANCE SPECTROSCOPY; MUTATION; PENICILLIUM; SULFURIC ACID ESTERS;

EID: 84940393571     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13085219     Document Type: Article

References (36)

1. Wang, H. J.; Gloer, J. B.; Scott, J. A.; Malloch, D. Coniochaetones A and B: New antifungal benzopyranones from the coprophilous fungus Coniochaeta saccardoi. Tetrahedron Lett. 1995, 36, 5847-5850.
2. Fujimoto, H.; Inagaki, M.; Satoh, Y.; Yoshida, E.; Yamazaki, M. Monoamine oxidase-inhibitory components from an ascomycete, Coniochaeta tetraspora. Chem. Pharm. Bull. 1996, 44, 1090-1092.
3. Khamthong, N.; Rukachaisirikul, V.; Phongpaichit, S.; Preedanon, S.; Sakayaroj, J. Bioactive polyketides from the sea fan-derived fungus Penicillium citrinum PSU-F51. Tetrahedron 2012, 68, 8245-8250.
4. Deng, L.; Niu, S.; Liu, X.; Che, Y.; Li, E. Coniochaetones E-I, new 4H-chromen-4-one derivatives from the Cordyceps-colonizing fungus Fimetariella sp. Fitoterapia 2013, 89, 8-14.
5. Ondeyka, J. G.; Zink, D.; Basilio, A.; Vicente, F.; Bills, G.; Diez, M. T.; Motyl, M.; Dezeny, G.; Byrne, K.; Singh, S. B. Coniothyrione, a chlorocyclopentandienylbenzopyrone as a bacterial protein synthesis inhibitor discovered by antisense technology. J. Nat. Prod. 2007, 70, 668-670.
6. Kong, F.; Zhu, T.; Pan, W.; Tsao, R.; Pagano, T. G.; Nguyen, B.; Marquez, B. WYE-120318, a ring contraction product of methylnaltrexone, and structure revision of coniothyrione. Magn. Reson. Chem. 2012, 50, 829-833.
7. Bungihan, M. E.; Tan, M. A.; Kitajima, M.; Kogure, N.; Franzblau, S. G.; De La Cruz, T. E. E.; Takayama, H.; Nonato, M. G. Bioactive metabolites of Diaporthe sp. P133, an endophytic fungus isolated from Pandanus amaryllifolius. J. Nat. Med. 2011, 65, 606-609.
8. Zhang, F.; Li, L.; Niu, S.; Si, Y.; Guo, L.; Jiang, X.; Che, Y. A thiopyranchromenone and other chromone derivatives from an endolichenic fungus, Preussia africana. J. Nat. Prod. 2012, 75, 230-237.
9. Saleem, M.; Tousif, M. I.; Riaz, N.; Ahmed, I.; Schulz, B.; Ashraf, M.; Nasar, R.; Pescitelli, G.; Hussain, H.; Jabbar, A.; Shafiq, N.; Krohn, K. Cryptosporioptide: A bioactive polyketide produced by an endophytic fungus Cryptosporiopsis sp. Phytochemistry 2013, 93, 199-202.
10. Kong, F.; Carter, G. T. Remisporine B, a novel dimeric chromenone derived from spontaneous Diels-Alder reaction of remisporine A. Tetrahedron Lett. 2003, 44, 3119-3122.
11. Hertweck, C. Hidden biosynthetic treasures brought to light. Nat. Chem. Biol. 2009, 5, 450-452.
12. Cichewicz, R. H.; Henrikson, J. C.; Wang, X.; Branscum, K. M. Strategies for accessing microbial secondary metabolites from silent biosynthetic pathways. In Manual of Industrial Microbiology and Biotechnology, 3rd ed.; Baltz, R. H., Davies, J. E., Demain, A. L., Bull, A. T., Junker, B., Katz, L., Lynd, L. R., Masurekar, P. C., Reeves, D., Zhao, H., Eds.; ASM Press: Washington, DC, USA, 2010; pp. 78-95.
13. Brakhage, A. A.; Schroeckh, V. Fungal secondary metabolites-Strategies to activate silent gene clusters. Fungal Genet. Biol. 2011, 48, 15-22.
14. Takahashi, J. A.; Teles, A. P. C.; Bracarense, A. A. P.; Gomes, D. C. Classical and epigenetic approaches to metabolite diversification in filamentous fungi. Phytochem. Rev. 2013, 12, 773-789.
15. Bode, H. B.; Bethe, B.; Höfs, R.; Zeeck, A. Big effects from small changes: Possible ways to explore nature's chemical diversity. ChemBioChem 2002, 3, 619-627.
16. Marmann, A.; Aly, A. H.; Lin, W.; Wang, B.; Proksch, P. Co-cultivation-A powerful emerging tool for enhancing the chemical diversity of microorganisms. Mar. Drugs 2014, 12, 1043-1065.
17. Henrikson, J. C.; Hoover, A. R.; Joyner, P. M.; Cichewicz, R. H. A chemical epigenetics approach for engineering the in situ biosynthesis of a cryptic natural product from Aspergillus niger. Org. Biomol. Chem. 2009, 7, 435-438.
18. Ochi, K.; Okamoto, S.; Tozawa, Y.; Inaoka, T.; Hosaka, T.; Xu, J.; Kurosawa, K. Ribosome engineering and secondary metabolite production. Adv. Appl. Microbiol. 2004, 56, 155-184.
19. Ochi, K. From microbial differentiation to ribosome engineering. Biosci. Biothenol. Biochem. 2007, 71, 1373-1386.
20. Hosaka, T.; Ohnishi-Kameyama, M.; Muramatsu, H.; Murakami, K.; Tsurumi, Y.; Kodani, S.; Yoshida, M.; Fujie, A.; Ochi, K. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat. Biotechnol. 2009, 27, 462-464.
21. Fu, P.; Jamison, M.; La, S.; MacMillan, J. B. Inducamides A-C, chlorinated alkaloids from an RNA polymerase mutant strain of Streptomyces sp. Org. Lett. 2014, 16, 5656-5659.
22. Cui, C.-B. A new approach for exploiting microbial new strain resources for drug screening. J. Int. Pharm. Res. 2010, 37, 1-7.
23. Wu, C.-J.; Cui, C.-B.; Tian, C.-K.; Li, C.-W. Antitumor metabolites produced by two Penicillium purpurogenum G59 mutants. J. Int. Pharm. Res. 2010, 37, 122-126.
24. Chai, Y.-J.; Cui, C.-B.; Li, C.-W.; Hua, W. Antitumor metabolites newly produced by a gentamicin-resistant mutant of Penicillium purpurogenum G59. J. Int. Pharm. Res. 2011, 38, 216-222.
25. Chai, Y.-J.; Cui, C.-B.; Li, C.-W.; Wu, C.-J.; Tian, C.-K.; Hua, W. Activation of the dormant secondary metabolite production by introducing gentamicin-resistance in a marine-derived Penicillium purpurogenum G59. Mar. Drugs 2012, 10, 559-582.
26. Wu, C.-J.; Yi, L.; Cui, C.-B.; Li, C.-W.; Wang, N.; Han, X. Activation of the silent secondary metabolite production by introducing neomycin-resistance in a marine-derived Penicillium purpurogenum G59. Mar. Drugs 2015, 13, 2465-2487.
27. Dong, Y.; Cui, C.-B.; Li, C.-W.; Hua, W.; Wu, C.-J.; Zhu, T.-J.; Gu, Q.-Q. Activation of dormant secondary metabolite production by introducing neomycin resistance into the deep-sea fungus, Aspergillus versicolor ZBY-3. Mar. Drugs 2014, 12, 4326-4352.
28. Fang, S.-M.; Wu, C.-J.; Li, C.-W.; Cui, C.-B. A practical strategy to discover new antitumor compounds by activating silent metabolite production in fungi by diethyl sulphate mutagenesis. Mar. Drugs 2014, 12, 1788-1814.
29. Fang, S.-M.; Cui, C.-B.; Li, C.-W.; Wu, C.-J.; Zhang, Z.-J.; Li, L.; Huang, X.-J.; Ye, W.-C. Purpurogemutantin and purpurogemutantidin, new drimenyl cyclohexenone derivatives produced by a mutant obtained by diethyl sulfate mutagenesis of a marine-derived Penicillium purpurogenum G59. Mar. Drugs 2012, 10, 1266-1287.
30. Xia, M.-W.; Cui, C.-B.; Li, C.-W.; Wu, C.-J. Three new and eleven known unusual C25 steroids: Activated production of silent metabolites in a marine-derived fungus by chemical mutagenesis strategy using diethyl sulphate. Mar. Drugs 2014, 12, 1545-1568.
31. Wu, C.-J.; Li, C.-W.; Cui, C.-B. Seven new and two known lipopeptides as well as five known polyketides: The activated production of silent metabolites in a marine-derived fungus by chemical mutagenesis strategy using diethyl sulphate. Mar. Drugs 2014, 12, 1815-1838.
32. Tian, C.-K.; Cui, C.-B.; Han, X.-X. Isolation of fungal strains in unusual environment and screening for their antitumor activity. J. Int. Pharm. Res. 2008, 35, 401-405.
33. Shao, C.; Wang, C.; Wei, M.; Gu, Y.; Xia, X.; She, Z.; Lin, Y. Structure elucidation of two new xanthone derivatives from the marine fungus Penicillium sp. (ZZF 32#) from the South China Sea. Magn. Reson. Chem. 2008, 46, 1066-1069.
34. Spartan'14; Wavefunction Inc.: Irvine, CA, USA, 2013.
35. Gaussian 09, Revision A.01; Gaussian Inc.: Wallingford, CT, USA, 2009.
36. Bruhn, T.; Hemberger, Y.; Schaumloffel, A.; Bringmann, G. SpecDis, Version 1.53; University of Wuerzburg: Wuerzburg, Germany, 2011.